NMC

NEA Management Company Portfolio holdings

AUM $1.33B
This Quarter Return
+2.46%
1 Year Return
+85.82%
3 Year Return
+531.37%
5 Year Return
+304.32%
10 Year Return
+4,927.96%
AUM
$1.43B
AUM Growth
+$1.43B
Cap. Flow
-$572M
Cap. Flow %
-40.04%
Top 10 Hldgs %
64.34%
Holding
48
New
3
Increased
2
Reduced
2
Closed
4
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
SBBP
26
DELISTED
Strongbridge Biopharma plc.
SBBP
$13M 0.91%
4,141,308
DZSI
27
DELISTED
DZS Inc. Common Stock
DZSI
$12.4M 0.87%
956,255
CSBR icon
28
Champions Oncology
CSBR
$95.8M
$12.2M 0.86%
1,562,500
SURF
29
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$9.35M 0.65%
3,315,149
RIGL icon
30
Rigel Pharmaceuticals
RIGL
$710M
$8.47M 0.59%
324,315
VRNA
31
Verona Pharma
VRNA
$9.18B
$6.22M 0.44%
1,219,674
KA
32
DELISTED
Kineta, Inc. Common Stock
KA
$5.42M 0.38%
39,691
XFOR icon
33
X4 Pharmaceuticals
XFOR
$70M
$5M 0.35%
11,111
PHXM
34
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
$4.47M 0.31%
62,500
TRVN
35
DELISTED
Trevena, Inc.
TRVN
$3.93M 0.28%
6,099
CTIC
36
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$3.22M 0.23%
3,750,000
RGLS
37
DELISTED
Regulus Therapeutics
RGLS
$2.57M 0.18%
205,246
+113,671
+124% +$1.42M
TCON
38
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$2.36M 0.17%
17,336
ELGX
39
DELISTED
Endologix Inc
ELGX
$1.8M 0.13%
249,021
XENE icon
40
Xenon Pharmaceuticals
XENE
$2.99B
$1.8M 0.13%
+182,754
New +$1.8M
VIRX
41
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$943K 0.07%
37,094
AKTX
42
Akari Therapeutics
AKTX
$21.4M
$913K 0.06%
22,608
TRIL
43
DELISTED
Trillium Therapeutics Inc.
TRIL
$691K 0.05%
2,100,000
AKAO
44
DELISTED
Achaogen, Inc.
AKAO
$99K 0.01%
5,215,128
ESTC icon
45
Elastic
ESTC
$9.17B
-5,562,153
Closed -$444M
ARQL
46
DELISTED
Arqule Inc
ARQL
-2,520,316
Closed -$12.1M
NITE
47
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
-1,214,285
Closed -$30.8M
CMTA
48
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
-2,707,734
Closed -$70.7M